These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36695584)

  • 1. Pharmacokinetic/Pharmacodynamic Index Linked to
    Jimenez-Toro I; Rodriguez CA; Zuluaga AF; Otalvaro JD; Perez-Madrid H; Vesga O
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0096622. PubMed ID: 36695584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone.
    Jimenez-Toro I; Rodriguez CA; Zuluaga AF; Otalvaro JD; Vesga O
    PLoS One; 2020; 15(12):e0243365. PubMed ID: 33290425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
    Werth BJ; Shireman LM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.
    Tran TT; Tam VH; Murray BE; Arias CA; Singh KV
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an
    Cusumano JA; Daffinee KE; Piehl EC; García-Solache M; Desbonnet C; Rice LB; LaPlante KL
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0042622. PubMed ID: 36154173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
    Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
    Westbrook KJ; Chilambi GS; Stellfox ME; Nordstrom HR; Li Y; Iovleva A; Shah NH; Jones CE; Kline EG; Squires KM; Miller WR; Tran TT; Arias CA; Doi Y; Shields RK; Van Tyne D
    J Antimicrob Chemother; 2024 Apr; 79(4):801-809. PubMed ID: 38334390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates.
    Cusumano JA; Khan R; Shah Z; Philogene C; Harrichand A; Huang V
    Microbiol Spectr; 2022 Aug; 10(4):e0062122. PubMed ID: 35703558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model.
    Thieme L; Hartung A; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2020 Aug; 75(8):2173-2181. PubMed ID: 32357212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?
    Herrera-Hidalgo L; de Alarcón A; López-Cortes LE; Luque-Márquez R; López-Cortes LF; Gutiérrez-Valencia A; Gil-Navarro MV
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Kidd JM; Abdelraouf K; Asempa TE; Humphries RM; Nicolau DP
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
    Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A
    Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Data Are Predictive of
    Connolly KL; Eakin AE; Gomez C; Osborn BL; Unemo M; Jerse AE
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.